Pluristem Therapeutics Inc., of Haifa, Israel, issued 2.5 million shares of common stock to CHA Bio&Diostech, of South Korea, in consideration for issuance to Pluristem about 1 million shares of CHA, for a total value of $10.4 million, at a price of $4.16 per Pluristem common share.